Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
about
Neuropilins: expression and roles in the epitheliumPrognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysisOne more piece of the puzzle? Adenosquamous carcinoma in a pancreatic mass.Pancreatic biomarkers: could they be the answer?A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival.McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinomaMeta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers.Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla.Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.Ploidy and DNA index as prognostic factors in resected pancreatic ductal adenocarcinoma - a review of the literature.Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer.Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer.Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancerThe inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival.EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trialThe prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the PancreasClinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysisThe Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer.Maximum Standard Uptake Value as a Clinical Biomarker for Detecting Loss of SMAD4 Expression and Early Systemic Tumor Recurrence in Resected Left-Sided Pancreatic Cancer.The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas.Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma.A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.Role of BAX for outcome prediction in gastrointestinal malignancies.Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.The VEGF pathway in lung cancer.Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinomaPrognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers.VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature.Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma.Recommendations for reporting histopathology studies: a proposalExpression of VEGF-D, SMAD4, and SMAD7 and Their Relationship with Lymphangiogenesis and Prognosis in Colon Cancer.
P2860
Q26998786-605D6CA7-E6B1-4CFA-9CFD-006C8BE847B1Q27027981-C9E7FCB5-FD86-4EA7-8810-C521CF34A974Q33352940-D552DF64-222B-4C3B-9B8C-9405FCBC25C5Q33801371-88A8D27A-1607-41C0-BBA7-24BE41E5D8AAQ34111214-F00DB843-9083-4288-873F-8321E6667114Q34168562-D79805A7-CCE0-43D3-BC34-5CBC1052A63AQ34344060-E6F2AAA0-3F58-4A21-B3AE-0262A74D3328Q34472484-C326E3ED-574C-4C52-AA8C-C528A2E38CF9Q34501943-38795E43-6D44-4FD2-80AE-C18BFD219CBEQ34990040-BC78387A-03E2-4F4E-9160-05892123EA34Q35095399-FDB75F65-7C22-42D7-BC7F-37A51EDB9003Q35150637-BE3DE523-E112-4D86-8E66-459C4AB9D355Q35680802-4D62699B-80E4-4700-BF4E-7D1CF2C99BFEQ35774267-FED62347-4118-401B-8B27-C8BCCE148B17Q35820525-DE9D9C97-48B0-4B51-B838-FB08A845815AQ36014381-27384A7D-82E6-4623-9FBD-73739435C756Q36131174-0B9B1A6D-CEFB-406F-87F9-6DBDC11D382CQ36200253-A18BD16C-C6B4-460D-AAB7-5080D5B49969Q36356232-0A6EC9C1-DBA2-4DD3-85E1-1E33BAEA01BDQ36378003-AC107FE5-42FB-4836-96CB-38831ACEAD34Q36405930-CDD79DC8-1F36-4687-896F-673626C7E09EQ36793866-96D3DFFF-4275-4B51-B67B-A99FFB09964BQ37134542-193C5E77-D4DC-4C46-AE24-A232A3744F12Q37206394-21D6809F-E4F1-4B55-9E54-58953706C75CQ37277702-58720B35-07E9-49E1-BE18-9F6E703142D7Q37495918-FE212FF7-DD09-47C5-BAF5-72787CFCF08FQ37738137-87F56D41-7147-4BE8-BF6C-3B310FDCD7B6Q38099265-70F36340-BE61-428C-AD67-401BDB19A9E0Q38108758-E14E26D2-5EED-49C7-8D6E-C6393199251AQ38148062-480F14B5-0E70-43B7-8E39-17C70C4C677AQ38148460-C3C2091C-AA01-4226-B144-B3811AE388C2Q38208583-EE933130-A7F3-4143-B9A6-F70A77979DE8Q38259982-76A3EF1E-4E68-49B8-8817-B23F3622DEB4Q38378638-DDA07D40-1355-4121-890B-9EFFF46BE17DQ38557111-081A692F-D9C0-4355-BE7C-F01249DDA125Q38681382-0A6BCF7D-94A2-4F65-903E-FF04378A9688Q38911733-8A1315CA-C232-40CF-977A-8ADDBA20E329Q41592795-7ADFC182-4A0C-47D0-9C46-DF40980CC1CDQ42571300-22F49CDE-8FE9-4938-AD4E-AAA681FDB305Q47665389-9BF6D38E-380E-4AEE-A099-D4E129269181
P2860
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
@en
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
@nl
type
label
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
@en
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
@nl
prefLabel
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
@en
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
@nl
P2093
P2860
P921
P356
P1476
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2011.110
P407
P577
2011-03-29T00:00:00Z